Zenzi

Thane, India Founded: 2005 • Age: 21 yrs
Develops and manufactures generic drugs through contract services and research.

About Zenzi

Zenzi is a Healthcare company based in Thane (India) founded in 2005. It develops and manufactures generic drugs through contract services and research. It operates on a B2B model. Its Indian entity Zenzi Pharmaceutical Industries Private Limited reported revenue of β‚Ή26.29 Cr. Zenzi offers products and services including Oral Solid Dosages and Injectables. Its focus areas include Pharmaceuticals, Research and Development, Drug Formulation and Generic Medicines. Its competitors include Inventia Healthcare, Zim Labs and Halewood Laboratories; 2 of its 3 listed competitors have raised funding.

Company details

Zenzi Pharmaceutical Industries focuses on developing and manufacturing generic medicinal products, including tablets, capsules, and injectables, via contract manufacturing. They operate state-of-the-art cGMP facilities in India, adhering to EU and WHO standards. Their activities involve research and development with skilled scientists, ensuring quality and innovation in global healthcare. They serve business clients through strategic partnerships and maintain strict GMP guidelines.

Key Metrics
  • Annual Revenue
    ₹26.29 Cr

    FY 2025 · -34% YoY

  • Net Loss
    -₹1.61 Cr

    FY 2025 · -6% margin

  • EBITDA
    ₹9.28 Cr

    FY 2025 · 35% margin

Products & Services of Zenzi

Zenzi offers a comprehensive portfolio of products and services, including Oral Solid Dosages and Injectables.

Oral Solid Dosages
Pharmaceutical Products

Manufactures tablets and capsules for generic drugs.

Injectables
Pharmaceutical Products

Produces injectable generic medicines for various uses.

Board of directors of Zenzi Pharmaceutical Industries Private Limited (Zenzi)

Zenzi Pharmaceutical Industries Private Limited is the primary company behind Zenzi. The board of Zenzi Pharmaceutical Industries Private Limited currently have 2 directors; the longest-serving is Jacob Sporon Fiedler, appointed in 2005. 7 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Jacob Sporon Fiedler
DIN 01660842
Director20 Dec 200520 yrs 10 moZenzi Pharmaceutical Industries Private Limited
Hrangdanglien
DIN 08458016
Director22 May 20197 yrs 5 moZenzi Pharmaceutical Industries Private Limited

Financials of Zenzi

Figures of Zenzi Pharmaceutical Industries Private Limited, the primary company behind Zenzi, for FY 2025. Revenue was ₹26.29 Cr (-34% year on year). Net loss was -₹1.61 Cr (-6% margin). EBITDA was ₹9.28 Cr (35% margin). Revenue has grown at a compounded annual rate of +7% over three years and +9% over five years.

  • ₹26.29 CrRevenue · FY 2025 · -34% YoY
  • -₹1.61 CrNet loss · -6% margin
  • ₹9.28 CrEBITDA · 35% margin
  • ₹105 CrPaid-up capital
  • +7%Revenue CAGR, 3 years
  • +9%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Zenzi Pharmaceutical Industries Private Limited are on its company page.

Premium access

Detailed financial statements for Zenzi

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Competitors of Zenzi

Zenzi has 3 listed competitors in our database, 2 of them funded. They include Inventia Healthcare, Zim Labs and Halewood Laboratories.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
inventiahealthcare.com1985Mumbai, India$42.49M980
Oral solid drug delivery systems are manufactured and developed.
zimlab.in1989Nagpur, India$8.2M598
Solid and semisolid dosage forms are developed and manufactured.
halewoodlabs.com1984Ahmedabad, India348
Provides contract manufacturing services for food, pharmaceuticals, and related products globally.
Premium access

Detailed competitors of Zenzi

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Zenzi

Premium access

Complete news archive for Zenzi

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Zenzi

Zenzi was founded in 2005.

Zenzi is headquartered in Thane, India. It is registered at Thane, Maharashtra, India.

The primary company behind Zenzi, Zenzi Pharmaceutical Industries Private Limited, reported revenue of β‚Ή26.29 Cr for FY 2025, down 34% year on year.

Zenzi Pharmaceutical Industries focuses on developing and manufacturing generic medicinal products, including tablets, capsules, and injectables, via contract manufacturing. They operate state-of-the-art cGMP facilities in India, adhering to EU and WHO standards. Their activities involve research and development with skilled scientists, ensuring quality and innovation in global healthcare. They serve business clients through strategic partnerships and maintain strict GMP guidelines.

Zenzi's top competitors include Inventia Healthcare, Zim Labs and Halewood Laboratories.

Zenzi offers Oral Solid Dosages and Injectables.

Zenzi operates through Zenzi Pharmaceutical Industries Private Limited.

The legal entities of Zenzi currently have 2 directors, including Hrangdanglien, Jacob Sporon Fiedler.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available